Diminished retinal complex lipid synthesis and impaired fatty acid β-oxidation associated with human diabetic retinopathy

JCI Insight. 2021 Oct 8;6(19):e152109. doi: 10.1172/jci.insight.152109.

Abstract

BACKGROUNDThis study systematically investigated circulating and retinal tissue lipid determinants of human diabetic retinopathy (DR) to identify underlying lipid alterations associated with severity of DR.METHODSRetinal tissues were retrieved from postmortem human eyes, including 19 individuals without diabetes, 20 with diabetes but without DR, and 20 with diabetes and DR, for lipidomic study. In a parallel study, serum samples from 28 American Indians with type 2 diabetes from the Gila River Indian Community, including 12 without DR, 7 with mild nonproliferative DR (NPDR), and 9 with moderate NPDR, were selected. A mass-spectrometry-based lipidomic platform was used to measure serum and tissue lipids.RESULTSIn the postmortem retinas, we found a graded decrease of long-chain acylcarnitines and longer-chain fatty acid ester of hydroxyl fatty acids, diacylglycerols, triacylglycerols, phosphatidylcholines, and ceramide(NS) in central retina from individuals with no diabetes to those with diabetes with DR. The American Indians' sera also exhibited a graded decrease in circulating long-chain acylcarnitines and a graded increase in the intermediate-length saturated and monounsaturated triacylglycerols from no DR to moderate NPDR.CONCLUSIONThese findings suggest diminished synthesis of complex lipids and impaired mitochondrial β-oxidation of fatty acids in retinal DR, with parallel changes in circulating lipids.TRIAL REGISTRATIONClinicalTrials.gov NCT00340678.FUNDINGThis work was supported by NIH grants R24 DK082841, K08DK106523, R03DK121941, P30DK089503, P30DK081943, P30DK020572, P30 EY007003; The Thomas Beatson Foundation; and JDRF Center for Excellence (5-COE-2019-861-S-B).

Keywords: Diabetes; Fatty acid oxidation; Ophthalmology; Retinopathy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • American Indian or Alaska Native
  • Arizona
  • Black or African American
  • Carnitine / analogs & derivatives
  • Carnitine / metabolism
  • Case-Control Studies
  • Ceramides / metabolism
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetic Retinopathy / etiology
  • Diabetic Retinopathy / metabolism*
  • Diglycerides / metabolism
  • Disease Progression
  • Esters / metabolism
  • Female
  • Hispanic or Latino
  • Humans
  • Lipidomics*
  • Male
  • Mass Spectrometry
  • Middle Aged
  • Mitochondria / metabolism
  • Phosphatidylcholines / metabolism
  • Retina / metabolism*
  • Triglycerides / metabolism
  • White People

Substances

  • Ceramides
  • Diglycerides
  • Esters
  • Phosphatidylcholines
  • Triglycerides
  • acylcarnitine
  • Carnitine

Associated data

  • ClinicalTrials.gov/NCT00340678